A nomogram was constructed, based on TTL and clinicopathologic factors also identified as predictive of non-SLN involvement, and included a tumor size > 20 mm, and NST treatment response, and HER2-negative status in combination with a Ki67 ≤ 20%. The gene discussed is ERBB2; the disease is neoplasm.